Sun Pharma to acquire 85% stake in Russia's Biosintez
The country's largest drug firm Sun Pharma on Wednesday said it has signed definitive agreements to acquire 85.1 percent stake in Russia-based JSC Biosintez for USD 24 million.
Nov 23, 2016, 12:59 PM IST